Saint-Louis, France

Denise Rageot

USPTO Granted Patents = 4 

 

 

Average Co-Inventor Count = 8.3

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Denise Rageot: Innovator in Neurological Treatments

Introduction

Denise Rageot is a prominent inventor based in Saint-Louis, France. She has made significant contributions to the field of medical science, particularly in the treatment of neurological disorders. With a total of three patents to her name, her work has the potential to impact many lives.

Latest Patents

Denise Rageot's latest patents focus on innovative compounds for treating neurological disorders. One of her notable inventions involves a compound of formula (I), which includes difluoromethyl-aminopyridines and difluoromethyl-aminopyrimidines. This invention relates to novel phosphoinositide 3-kinase (PI3K), mammalian target of rapamycin (mTOR), and PI3K-related kinase (PIKKs) inhibitor compounds. These compounds are designed to be useful, either alone or in combination with further therapeutic agents, for treating disorders mediated by lipid kinases.

Career Highlights

Throughout her career, Denise has worked with esteemed institutions such as Universität Basel and Torqur AG. Her experience in these organizations has allowed her to develop her innovative ideas and contribute to significant advancements in her field.

Collaborations

Denise Rageot has collaborated with notable professionals, including Paul Hebeisen and Florent Beaufils. These partnerships have enriched her research and expanded the scope of her inventions.

Conclusion

Denise Rageot is a trailblazer in the field of neurological treatments, with her innovative patents paving the way for new therapeutic options. Her dedication to research and collaboration highlights her commitment to improving healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…